Follow The Filings

VRSK Verisk

Industrials, filed as VERISK ANALYTICS INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 3 managers in 2026 Q2, sold by 2

  • 1 Owner
  • #193
  • Max 0.2%
  • Master 0.06%
  • $26M
  • 1 exit

In 2026 Q3 Torray Investment Partners sold out of Verisk.

Who owns this now

Largest portfolio weights among holders, up to 0.2% (Thomas Gayner, Markel Group). Not free-float ownership.

  1. Thomas Gayner 0.20%

Who owns VRSK

Sorted by value, long equity only, as of 2026 Q3.

History
Thomas Gayner, Markel Group 0.20% Hold 155,950 $26M History
Torray Investment Partners exited 2026 Q3 Last 2026 Q2 0.59% Exit −0.59% 24,309 $4.4M History

1 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by VRSK's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VRSK insider trades
  • $764K bought by 5 insiders
  • $2.4M sold by 2 insiders outside a trading plan
  • $4.5M sold by 3 insiders under 10b5-1 plans
  1. Elizabeth Mann CFO
    Planned sale
    $74K 400 shares at $184.85 2.2% of stake
    Traded Oct 15 Filed Oct 16
    ↗
  2. Lee Shavel CEO
    Planned sale
    $603K 3,535 shares at $170.70 3.5% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  3. Elizabeth Mann CFO
    Planned sale
    $74K 400 shares at $184.91 2.2% of stake
    Traded Sep 15 Filed Sep 16
    ↗
  4. Lee Shavel CEO
    Planned sale
    $684K 3,535 shares at $193.43 3.5% of stake
    Traded Sep 1 Filed Sep 2
    ↗
  5. Elizabeth Mann CFO
    Planned sale
    $72K 400 shares at $179.95 2.1% of stake
    Traded Aug 17 Filed Aug 17
    ↗
  6. Lee Shavel CEO
    Planned sale
    $696K 3,535 shares at $196.94 3.5% of stake
    Traded Aug 3 Filed Aug 3
    ↗
  7. Kathy Card Beckles Chief Legal Officer
    Sale
    $395K 2,020 shares at $195.49 15% of stake
    Traded Jul 31 Filed Jul 31
    ↗
  8. Lee Shavel CEO
    Planned sale
    $550K 2,500 shares at $220.00 2.5% of stake
    Traded Jul 29 Filed Jul 31
    ↗
  9. Elizabeth Mann CFO
    Planned sale
    $77K 400 shares at $192.11 2.1% of stake
    Traded Jul 15 Filed Jul 15
    ↗
  10. Elizabeth Mann CFO
    Planned sale
    $72K 400 shares at $179.54 2% of stake
    Traded Jun 15 Filed Jun 16
    ↗
  11. Samuel G Liss Director
    Sale
    $851K 4,671 shares at $182.21 6.3% of stake
    Traded Jun 5 Filed Jun 8
    ↗
  12. Samuel G Liss Director
    Sale
    $1.2M 6,765 shares at $177.63 8.9% of stake
    Traded Jun 2 Filed Jun 4
    ↗
  13. Bruce Edward Hansen Director
    Planned sale
    $409K 2,336 shares at $174.99 13% of stake
    Traded Jun 1 Filed Jun 1
    ↗
  14. Bruce Edward Hansen Director
    Planned sale
    $400K 2,335 shares at $171.51 13% of stake
    Traded May 22 Filed May 26
    ↗
  15. Elizabeth Mann CFO
    Planned sale
    $64K 400 shares at $159.22 2% of stake
    Traded May 15 Filed May 15
    ↗

Also filed in the last 12 months, not counted as buying or selling: 41 stock grants, 11 share withholdings for taxes, and 7 option exercises.

Congress

7 members of Congress traded VRSK in the last three years: 9 buys and 10 sales. 5 members listed it in 2025 annual reports.

All Congress trades
  1. Gilbert Ray Cisneros, Jr. D-CA-31 Partial sale $1K–$15K Aug 18 filed Sep 10
  2. Julie Johnson D-TX-32Joint Buy $1K–$15K Oct 30, 2025 filed Aug 5
  3. Julie Johnson D-TX-32Joint Sell $1K–$15K Oct 30, 2025 filed Aug 5
  4. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  5. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Jun 16 filed Jul 2
  6. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K May 15 filed Jun 8

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 5.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.68B $2.88B $3.07B
Gross profit * $1.8B $1.98B $2.15B
Gross margin * 67.3% 68.7% 69.9%
Net income $614.6M $958.2M $908.3M
Net margin * 22.9% 33.3% 29.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.81B $0.912B $2.77B
Total non-current assets * $3.56B $3.35B $3.43B
Total assets $4.37B $4.26B $6.2B
Total current liabilities $0.771B $1.24B $2.3B
Total non-current liabilities * $3.27B $2.92B $3.59B
Total equity $310M $100.1M $309M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.06B $1.14B $1.44B
Cash from investing $2.75B -$0.125B -$0.358B
Cash from financing -$3.79B -$1.03B $0.795B
Net change in cash $0.01B -$0.012B $1.89B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.